Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,503,511
+$380,843 QoQ
Shares Held
9,675
+9.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.98%
of 13F equity value
Holder Rank
#997
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ceeto Capital Group, LLC holds $22,200,435 across 8 Drug Manufacturers - General names. AMGN ranks #4 (15.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
20,290 | $5,105,775 | |
| 2 | MRK |
Merck & Co., Inc.
|
29,864 | $3,837,524 | |
| 3 | LLY |
ELI LILLY & Co
|
3,030 | $3,634,273 | |
| 4 | AMGN |
Amgen Inc
This page
|
9,675 | $3,503,511 | |
| 5 | JNJ |
Johnson & Johnson
|
8,418 | $2,137,919 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
33,250 | $1,915,865 | |
| 7 | PFE |
Pfizer Inc
|
53,250 | $1,282,260 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,200 | $783,308 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,503,511 | 9,675 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,122,668 | 8,875 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,904,876 | 8,875 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,222,325 | 7,875 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,198,778 | 7,875 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,352,202 | 7,550 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,967,832 | 7,550 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,432,685 | 7,550 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,671,447 | 8,550 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,430,936 | 8,550 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,462,571 | 8,550 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,297,898 | 8,550 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,609,645 | 7,250 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,752,687 | 7,250 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,904,140 | 7,250 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,634,150 | 7,250 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,763,925 | 7,250 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,753,195 | 7,250 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,856,002 | 8,250 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,754,362 | 8,250 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,010,937 | 8,250 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,052,682 | 8,250 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,896,840 | 8,250 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,096,820 | 8,250 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,945,845 | 8,250 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,672,522 | 8,250 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||